Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation

Authors

Angela M. Halstead, Washington University School of Medicine in St. Louis
Chiraag D. Kapadia, Washington University School of Medicine in St. Louis
Jennifer Bolzenius, Washington University School of Medicine in St. Louis
Clarence E. Chu, Washington University School of Medicine in St. Louis
Andrew Schriefer, Washington University School of Medicine in St. Louis
Lukas D. Wartman, Washington University School of Medicine in St. Louis
Gregory R. Bowman, Washington University School of Medicine in St. Louis
Vivek K. Arora, Washington University School of Medicine in St. Louis

Journal

Elife

Publication Date

2017

Volume

6

Issue

e30862

Inclusive Pages

1-27

Document Type

Open Access Publication

DOI

10.7554/eLife.30862

Rights and Permissions

Halstead AM, Kapadia CD, Bolzenius J, Chu CE, Schriefer A, Wartman LD, Bowman GR, Arora VK. 2017. Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation. Elife. 2017 Nov 16;6. pii: e30862. doi: 10.7554/eLife.30862.

Recommended Citation

Halstead, Angela M.; Kapadia, Chiraag D.; Bolzenius, Jennifer; Chu, Clarence E.; Schriefer, Andrew; Wartman, Lukas D.; Bowman, Gregory R.; and Arora, Vivek K., "Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation." Elife. 6, e30862. 1-27. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6447